Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,940 | 10 | 63.7% |
| Food and Beverage | $9,888 | 364 | 30.1% |
| Travel and Lodging | $1,674 | 7 | 5.1% |
| Education | $363.04 | 10 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $25,607 | 147 | $0 (2024) |
| Stryker Corporation | $1,061 | 10 | $0 (2019) |
| PFIZER INC. | $566.31 | 28 | $0 (2023) |
| Teleflex LLC | $565.32 | 9 | $0 (2024) |
| Boston Scientific Corporation | $545.53 | 11 | $0 (2024) |
| Axonics, Inc. | $408.40 | 8 | $0 (2023) |
| ABBVIE INC. | $339.46 | 18 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $296.40 | 5 | $0 (2018) |
| NeoTract Inc. | $294.02 | 9 | $0 (2020) |
| Janssen Biotech, Inc. | $272.20 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $894.35 | 25 | Boston Scientific Corporation ($137.42) |
| 2023 | $913.10 | 29 | Teleflex LLC ($199.62) |
| 2022 | $1,528 | 28 | Astellas Pharma US Inc ($893.87) |
| 2021 | $1,569 | 61 | Axonics, Inc. ($366.20) |
| 2020 | $2,987 | 28 | Astellas Pharma US Inc ($2,655) |
| 2019 | $4,491 | 69 | Astellas Pharma US Inc ($2,758) |
| 2018 | $16,949 | 83 | Astellas Pharma US Inc ($15,912) |
| 2017 | $3,534 | 68 | Astellas Pharma US Inc ($2,885) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/26/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/19/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $107.08 | General |
| Category: Urology | ||||||
| 06/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/14/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $96.64 | General |
| Category: UROLOGY | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 03/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 03/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 03/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $137.42 | General |
| Category: General - Embolics_PI | ||||||
| 02/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/29/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 01/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Oncology | ||||||
| 01/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,247 | 5,018 | $334,975 | $96,435 |
| 2022 | 10 | 1,112 | 3,583 | $217,173 | $83,828 |
| 2021 | 12 | 1,174 | 3,640 | $195,897 | $90,123 |
| 2020 | 12 | 878 | 4,401 | $203,127 | $84,531 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 288 | $74,030 | $25,144 | 34.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 3,400 | $41,850 | $16,871 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $51,055 | $15,182 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 204 | $32,220 | $12,890 | 40.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 56 | 68 | $45,560 | $11,467 | 25.2% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 25 | 28 | $42,000 | $8,023 | 19.1% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 76 | 76 | $17,860 | $2,395 | 13.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 388 | 598 | $11,960 | $2,028 | 17.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 154 | 217 | $15,165 | $1,655 | 10.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,275 | $780.39 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 320 | $66,980 | $29,445 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 211 | $28,525 | $13,666 | 47.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 56 | 67 | $36,790 | $12,616 | 34.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 14 | 2,050 | $20,000 | $10,057 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $20,350 | $7,827 | 38.5% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 14 | 15 | $13,500 | $4,488 | 33.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 356 | 586 | $8,348 | $2,010 | 24.1% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 51 | 55 | $10,360 | $1,847 | 17.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 127 | 192 | $11,070 | $1,523 | 13.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 24 | 25 | $1,250 | $348.95 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 290 | $50,750 | $26,920 | 53.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 186 | 239 | $29,875 | $15,256 | 51.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 49 | 69 | $27,600 | $12,058 | 43.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 15 | 2,001 | $17,600 | $9,696 | 55.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 62 | 62 | $13,950 | $7,080 | 50.8% |
About Dr. Kimberly Berni, MD
Dr. Kimberly Berni, MD is a Urology healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245289677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimberly Berni, MD has received a total of $32,865 in payments from pharmaceutical and medical device companies, with $894.35 received in 2024. These payments were reported across 391 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,940).
As a Medicare-enrolled provider, Berni has provided services to 4,411 Medicare beneficiaries, totaling 16,642 services with total Medicare billing of $354,918. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Saint Peters, MO
- Active Since 05/10/2006
- Last Updated 04/15/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1245289677
Products in Payments
- MYRBETRIQ (Drug) $16,737
- Myrbetriq (Drug) $3,517
- XTANDI (Drug) $1,150
- MIRABEGRON (Drug) $1,107
- ACCOLADE (Device) $878.54
- UROLIFT (Device) $376.09
- Noctiva (Drug) $296.40
- Xtandi (Drug) $289.24
- Bulkamid (Device) $288.10
- UroLift (Device) $280.70
- BOTOX (Biological) $249.41
- XIAFLEX (Biological) $212.15
- UroLift System (Device) $189.23
- Erleada (Drug) $183.95
- TRIATHLON (Device) $182.21
- Rezum Generator (Device) $179.22
- ELIGARD (Drug) $171.82
- Androgel (Drug) $155.41
- CONTINENCE CARE (Device) $151.66
- Urocit-K (Drug) $137.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Saint Peters
Dr. Jeffrey Glaser, Md, MD
Urology — Payments: $28,862
Majdee Islam, M.d, M.D
Urology — Payments: $22,761
Ronan Lev, Md, MD
Urology — Payments: $8,676
Asim Razzaq, Md, MD
Urology — Payments: $6,032
Joseph Levy, Md, MD
Urology — Payments: $3,539
Dr. Omar Dawood, Md, MD
Urology